Literature DB >> 34314523

Renal lipotoxicity: Insights from experimental models.

Barbara Bruna Abreu Castro1,2, Orestes Foresto-Neto3, Niels Olsen Saraiva-Camara3, Helady Sanders-Pinheiro1,2.   

Abstract

In recent decades, there has been a progressive increase in the prevalence of obesity and chronic kidney disease. Renal lipotoxicity has been associated with obesity. Although lipids play fundamental physiological roles, the accumulation of lipids in kidney cells may cause dysfunction and/or renal fibrosis. Adipose tissue that exceeds their lipid storage capacity begins to release triglycerides into the bloodstream that can get stored in several organs, including the kidneys. The mechanisms underlying renal lipotoxicity involve intracellular lipid accumulation and organelle dysfunction, which trigger oxidative stress and inflammation that consequently result in insulin resistance and albuminuria. However, the specific pathways involved in renal lipotoxicity have not yet been fully understood. We aimed to summarize the current knowledge on the mechanisms by which lipotoxicity affects the renal morphology and function in experimental models of obesity. The accumulation of fatty acids in tubular cells has been described as the main mechanism of lipotoxicity; however, lipids and their metabolism also affect the function and the survival of podocytes. In this review, we presented indication of mitochondrial, lysosomal and endoplasmic reticulum alterations involved in kidney damage caused by obesity. The kidney is vulnerable to lipotoxicity, and studies of the mechanisms underlying renal injury caused by obesity can help identify therapeutic targets to control renal dysfunction.
© 2021 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  fatty acids; high-fat diet; hyperlipidaemia; kidney diseases; lipid metabolism disorders

Mesh:

Year:  2021        PMID: 34314523     DOI: 10.1111/1440-1681.13556

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

Review 1.  Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.

Authors:  Sze Kiat Tan; Helen Y Hougen; Jaime R Merchan; Mark L Gonzalgo; Scott M Welford
Journal:  Nat Rev Urol       Date:  2022-10-03       Impact factor: 16.430

Review 2.  The Roles of Fatty Acids and Apolipoproteins in the Kidneys.

Authors:  Xiaoyue Pan
Journal:  Metabolites       Date:  2022-05-20

3.  The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity.

Authors:  Elad Ben-Cnaan; Anna Permyakova; Shahar Azar; Shira Hirsch; Saja Baraghithy; Liad Hinden; Joseph Tam
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 4.  Adipose Stromal/Stem Cell-Derived Extracellular Vesicles: Potential Next-Generation Anti-Obesity Agents.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Valentina Di Liberto; Monica Frinchi; Francesco Caciagli; Vanni Caruso; Renata Ciccarelli; Giuseppa Mudò; Patrizia Di Iorio
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

5.  Sirtuin 3 Deficiency Aggravates Kidney Disease in Response to High-Fat Diet through Lipotoxicity-Induced Mitochondrial Damage.

Authors:  Monica Locatelli; Daniela Macconi; Daniela Corna; Domenico Cerullo; Daniela Rottoli; Giuseppe Remuzzi; Ariela Benigni; Carlamaria Zoja
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

6.  Oxidative Stress and Lipid Dysregulation in Lipid Droplets: A Connection to Chronic Kidney Disease Revealed in Human Kidney Cells.

Authors:  Zhen Chen; Rojeet Shrestha; Xiaoyue Yang; Xunzhi Wu; Jiaping Jia; Hitoshi Chiba; Shu-Ping Hui
Journal:  Antioxidants (Basel)       Date:  2022-07-18

Review 7.  Effects of female obesity on conception, pregnancy and the health of offspring.

Authors:  Wei Wei; Xing Zhang; Baotong Zhou; Bo Ge; Jing Tian; Jian Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.